A London-based research team has turned – successfully – to crowd-funding to gain backing for research on the use of the malaria drug artesunate to treat colorectal cancer.
A small clinical trial at St George’s, University of London, involving 20 patients, has show promising results.
The doctors involved in the project have been awarded £200,000 by the charity Bowel Disease UK – but say they need another £50,000 to purchase the drug for a large clinical trial, which would involve 140 patients.
They are using a scientific crowdfunding site, which allows members of the public to donate to innovative science and medical research projects.
Last night the researchers had already achieved nearly 75% of their funding, with donations from 237 people.
Colorectal cancer surgeon Professor Devinder Kumar said: “I’m extremely excited about this.
“We already know this is a safe drug that has been taken by tens of millions of people around the world to treat malaria. It only costs about 70p per tablet compared to the £20 or £30 you might expect to spend on a daily dose of chemotherapy.
“If we can repeat the results of this small study in a larger trial this could really be a ground breaker in the treatment of bowel cancer and one that wouldn’t bankrupt the NHS.”

Leave a Reply